Healthcare Policy Battles: Court Ruling and Price Transparency Legislation
Key Questions
What ACA Marketplace changes were blocked by the court?
A federal judge issued an injunction halting CMS’s 2027 NBPP rule changes on eligibility verification, subsidy reconciliation, and plan design. The ruling could become a major midterm healthcare issue.
What progress has price-transparency legislation made?
The Lower Costs, More Transparency Act passed the House Energy & Commerce Committee 45-0, while the Senate’s Patients Deserve Price Tags Act focuses on advance EOBs. Key divides remain over price-estimator tools versus actual listed prices.
How does Medina v. Planned Parenthood affect Medicaid enforcement?
The Supreme Court eliminated private lawsuits to enforce Medicaid provider requirements, shifting oversight to HHS. The decision weakens beneficiary protections and aligns with broader executive-power trends.
Federal court issued injunction blocking key ACA Marketplace rule changes from CMS's 2027 NBPP, including eligibility verification, subsidy reconciliation, and plan design changes. Could become major healthcare flashpoint ahead of midterms. Separately, healthcare price transparency legislation is gaining bipartisan momentum: Lower Costs, More Transparency Act passed 45-0 in House E&C; Senate's Patients Deserve Price Tags Act focuses on advance EOBs; House bills expand requirements to labs and imaging centers. Key dividing point: price estimator tools vs. actual price listings. Ownership disclosure requirements could add compliance burden. Additionally, SCOTUS in Medina v. Planned Parenthood eliminated private enforcement of Medicaid provider requirements, shifting oversight to HHS and weakening beneficiary protections beyond abortion—aligns with executive power consolidation trend.